Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment-Reference-Cited by-同舟云学术

Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment

Published:2021-12 Issue: Volume:340 Page:318-330
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Salmaso Stefano,Mastrotto Francesca,Roverso Marco,Gandin Valentina,De Martin Sara,Gabbia Daniela,De Franco Michele,Vaccarin Christian,Verona Marco,Chilin Adriana,Caliceti Paolo,Bogialli Sara,Marzaro Giovanni

Funder

Università degli Studi di Padova

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference48 articles.

1. Tyrosine kinase inhibitors in cancer: breakthrough and challenges of targeted therapy;Pottier;Cancers (Basel),2020

2. A comprehensive review of protein kinase inhibitors for cancer therapy;Kannaiyan;Expert. Rev. Anticancer. Ther.,2018

3. Targeting cancer with small molecule kinase inhibitors;Zhang;Nat. Rev. Cancer,2009

4. Rational design of inhibitors that bind to inactive kinase conformations;Liu;Nat. Chem. Biol.,2006

5. Targeting kinases with anilinopyrimidines: Discovery of N-phenyl-N'-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of class III receptor tyrosine kinase subfamily;Gandin;Sci. Rep.,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Playing Hide-and-Seek with Tyrosine Kinase Inhibitors: Can We Overcome Administration Challenges?;The AAPS Journal;2024-06-11

2. Advancing liposome technology for innovative strategies against malaria;Saudi Pharmaceutical Journal;2024-06

3. Recent advances in engineering prodrug-based nanomedicines for cancer therapy;Materials Advances;2024

4. Phospholipid-hitchhiked Paclitaxel Nanoprodrugs for Tumor Treatment;ACTA POLYM SIN;2023

5. Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery;Pharmaceutics;2022-12-24